Cervical Cancer and Human Papilloma Virus: South African Guidelines for Screening and Testing 2010

Authors

  • South African HPV Advisory Board University of Pretoria

Keywords:

Cervical Cancer, Human Papilloma Virus, screening, testing

Abstract

Cervical carcinoma is still the most common cancer of women on the African continent. Mortality remains high – worldwide at 50% – mainly because of late presentation, advanced stage of disease and absence of a functioning screening process. The aetiological link between human papillomavirus (HPV) infection and cervical cancer has been well established and a number of high-risk HPV genotypes have been identifi ed. HPV infection is the most common sexually transmitted infection (STI) in the world today – up to 80% of sexually active females will harbour HPV at some point in their lives. The majority of women will experience natural elimination of HPV infection because of an intact immune system. Persistent infection with a high risk type HPV puts women at high risk to develop precursors of cervical cancer or carcinoma itself. As part of a public health response to this serious problem, several HPV vaccines are under development. Use of vaccines still poses unanswered questions in many respects.

Author Biography

  • South African HPV Advisory Board, University of Pretoria

    Department of Obstetrics and Gynaecology

    University of Pretoria

Downloads

Issue

Vol. 2 No. 1 (2010)

Section

Clinical Guidelines

License

By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.